References
- Finegold SM. Anaerobic Bacteria in Human disease. Academic Press Inc, FL, USA (1977).
- ••A comprehensive overview of paststudies on all anaerobic infections.
- Brook I. Pediatric anaerobic infections. Marcel Dekker, Inc., NY, USA (2002).
- •• This textbook provides detailed information on the diagnosis and treatment of anaerobic infections in children and adolescents.
- Snydman DR, Jacobus NV, McDermott LA, et al. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antirnicrob. Agents Chernothet: 43, 2417–2422 (1999).
- •• This study provides susceptibility data on Bacterioides fragilis.
- Sutter VL, Finegold SM. Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antirnicrob. Agents Chernother. 10, 736–752 (1976).
- Brook I. The role of B-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect. Dis. 6, 601–607 (1984).
- Hoellman DB, Kelly LM, Credito K, et al In vitro anti-anaerobic activity of ertapenem (MK-0826) compared to seven other compounds. Antirnicrob. Agents Chernother 46, 220–224 (2002).
- Goldstein EJ. Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety. Clin. Infect. Dis. 23, S25—S30 (1996).
- Saito T, Senda K, Takakura S, etal. Anaerobic bacteremia: the yield of positive anaerobic blood cultures: patient characteristics and potential risk factors. Clin. Chem. Lab. Med. 41, 293–297 (2003).